p. 1 of 23

Revised 07/26/2019

Curriculum Vita Paul F. Malloy, Ph.D.

Business Address: Butler Hospital 345 Blackstone Boulevard Providence, RI 02906 E-mail: Paul_Malloy@brown.edu Home page: http://research.brown.edu/myresearch/Paul_Malloy Education: 1972 B.A., Psychology, with Honors, Dartmouth College 1980 M.A., Clinical Psychology, State University of New York, Binghamton 1981 Ph.D., Clinical Psychology, State University of New York, Binghamton 1981 Internship, Clinical Psychology, University of Mississippi Medical Center Honors and awards: 1995 Brown DPHB Outstanding Teaching Award in Psychology 1995 Fellow, National Academy of Neuropsychology 2002 Fellow, American Neuropsychiatric Association 2002 Dean’s Teaching Excellence Award, Brown Medical School 2003 Dean’s Teaching Excellence Award, Brown Medical School 2007 Dean’s Teaching Excellence Award, Brown Medical School 2010 Exemplary Teaching Certificate in Brain Sciences, Brown Medical School 2012 Exemplary Teaching Certificate in Brain Sciences, Brown Medical School 2015 Exemplary Teaching Certificate in Brain Sciences, Brown Medical School 2015 Brown DPHB Caldwell Award for Excellence in Teaching Military service: 1972-1976 Lieutenant, U.S. Navy Professional licensure and certification: 1983- Licensed Psychologist, Rhode Island, #261 1982-1983 Licensed Psychologist, Mississippi, #275 Academic appointments: 2009- Professor, Psychiatry & Human Behavior, Alpert Medical School, Brown University 1991-2009 Associate Professor, Psychiatry & Human Behavior, Brown Medical School 1983-1991 Assistant Professor, Psychiatry & Human Behavior, Brown Medical School 1982-1983 Assistant Professor, Psychiatry & Human Behavior, Univ. of Mississippi Med School 1981-1982 Instructor, Psychiatry & Human Behavior, Univ of Mississippi Medical School Hospital appointments: 1998- Co-Director, Butler Hospital Memory Disorders Clinic 1996- Director of Psychology, Butler Hospital, Providence, RI 1986-1995 Consulting Neuropsychologist, VA Medical Center, Providence, RI 1985-1995 Consulting Neuropsychologist, Miriam Hospital, Providence, RI 1985-1986 Consulting Neuropsychologist, St. Joseph Hospital, Providence, RI 1983-1996 Staff Neuropsychologist, Butler Hospital, Providence, RI 1981-1983 Staff Neuropsychologist, V.A. Medical Center, Jackson, MS

p. 2 of 23

Revised 07/26/2019

Hospital committees: 1997-2018 Information Services Planning Committee, Butler Hospital 1983- Institutional Review Board, Butler Hospital, Vice Chair 1983-2017 Library Committee, Butler Hospital, Chair 2008-2016 Electronic Medical Record Implementation Committee 2016-2018 Care New England Epic Implementation Committee University committees: 2000-2010 Brown University Psychology Training Consortium, Associate Director 1983-2000 Brown University Psychology Training Consortium

Neuropsychology Track Coordinator Training Committee Admissions Committee

1996-2015 Webmaster, Brown Dept. of Psychiatry & Human Behavior 2010- Department of Psychiatry and Human Behavior, Appointments and Promotions Committee Membership and activities in professional societies: 1983- National Academy of Neuropsychology 1983- International Neuropsychological Society 1983- American Psychological Association, Division 40 (Neuropsychology) 1993-2019 American Neuropsychiatric Association 1993-2007 American Neuropsychiatric Association, Research Committee 1993-2014 American Neuropsychiatric Association, Chair, Website Committee 1993-2014 American Neuropsychiatric Association, Advisory Committee 1999-2019 American Neuropsychiatric Association, Annual Meeting program committee 1999 International Neuropsychological Society, Annual Meeting program committee 2000-2005 International Neuropsychological Society, Continuing Education Committee 2000-2005 National Academy of Neuropsychology, Professional Affairs & Information Office 2002-2003 Association for Internship Training in Clinical Neuropsychology Board Member 2006 American Psychological Association Div. 40 Annual Meeting Program Committee

Publications Electronic publications: None Original publications in peer-reviewed journals: 1. Twentyman, C. S., Malloy. P. F., & Green, L. (1979). Instructed heart rate control in a high heart rate

population. Journal of Behavioral Medicine, 2, 251-261. 2. Malloy, P. F. & Webster, J. S. (1981). Detecting mild brain impairment using the Luria-Nebraska

Neuropsychological Battery. Journal of Consulting and Clinical Psychology, 49, 768-770. 3. Stefan, C. & Malloy, P. F. (1982). An investigation of the construct validity of the Bannister-

Fransella Grid Test of Schizophrenic Thought Disorder. British Journal of Clinical Psychology, 21, 199-204.

4. Malloy, P. F., Fairbank, J. A., & Keane, T. M. (1983). Validation of a multimethod assessment of post-traumatic stress disorders in Vietnam veterans. Journal of Consulting and Clinical Psychology, 51, 488-494.

p. 3 of 23

Revised 07/26/2019

5. Fairbank, J. A., Keane, T. M., & Malloy, P. F. (1983). Some preliminary information on the psychological characteristics of Vietnam veterans with posttraumatic stress disorders. Journal of Consulting and Clinical Psychology, 51, 912-919.

6. Keane, T. M., Malloy, P. F., & Fairbank, J. F. (1984). The empirical development of an MMPI subscale for the assessment of combat-related posttraumatic stress disorders. Journal of Consulting and Clinical Psychology, 52, 888-891.

7. McCaffrey, R. J., Malloy, P. F., & Brief, D. (1985). Internship opportunities in clinical neuropsychology emphasizing recent INS guidelines. Professional Psychology, 16, 236-252.

8. Malloy, P. F., Webster, J. S., & Russell, W. (1985). Tests of Luria's frontal lobe syndromes. International Journal of Clinical Neuropsychology, 7, 88-95.

9. Malloy, P. F. & Levis, D. J. (1988). A laboratory demonstration of persistent human avoidance. Behavior Therapy, 19, 229-241.

10. Nadeau, S. E., Malloy, P. F., & Andrew, M. E. (1988). A crossover trial of bromocriptine in the treatment of vascular dementia. Annals of Neurology, 24, 270-272.

11. Kohn, R., Lilly, R. B., Sokol, M.S., & Malloy, P. F. (1989). Psychiatric presentations of intracranial cysts. Journal of Neuropsychiatry and Clinical Neurosciences, 1, 60-66.

12. Malloy, P. F., Rasmussen, S., Braden, W. and Haier, R. (1989). Topographic evoked potential mapping in obsessive-compulsive disorder: Evidence of frontal lobe dysfunction. Psychiatry Research, 28, 63-71.

13. Malloy, P. F., Noel, N., Longabaugh, R., Rogers, S., & Beatty, M. (1989). Risk factors for neuropsychological impairment in alcoholics: Antisocial personality, age, years of drinking, and gender. Journal of Studies on Alcohol, 50, 422-426.

14. Kohn, R., Lilly, R. B., Sokol, M.S., & Malloy, P. F. (1989). Localized neuropsychiatric symptoms of an intracranial cyst. Journal of Neuropsychiatry and Clinical Neurosciences, 1, 446.

15. Malloy, P.F. & Levis, D.J. (1990). A human laboratory test of Eysenck’s theory of incubation: A search for the resolution of the neurotic paradox. Journal of Psychopathology and Behavioral Assessment, 12, 309-327.

16. Malloy, P. F., Noel, N., Longabaugh, R., & Beattie, M. (1990). Determinants of neuropsychological impairment in antisocial substance abusers. Addictive Behaviors, 15, 431-438.

17. Malloy, P. F., Mishra, S., & Adler, S. (1990). Neuropsychological deficits in myotonic muscular dystrophy. Journal of Neurology, Neurosurgery, and Psychiatry, 53, 1011-1013.

18. Richardson, E. D., Malloy, P. F., Longabaugh, R., Williams, J., Noel, N., & Beattie, M.A. (1991). Liver function tests and neuropsychological impairment in substance abusers. Addictive Behaviors, 16, 51-55.

19. Richardson, E. D., Malloy, P. F., & Grace, J. (1991). Othello syndrome following right cerebrovascular infarct. Journal of Geriatric Psychiatry and Neurology, 4, 160-165.

20. Malloy, P. F., Cimino, C., & Westlake, R. (1992). Differential diagnosis of primary and secondary Capgras delusions. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 5, 83-96.

21. Grace, J. & Malloy, P. F. (1992). Neuropsychiatric presentations of right hemisphere developmental disability. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 5, 194-204.

22. Malloy, P.F., Bihrle, A., Duffy, J., & Cimino, C. (1993). The orbitomedial frontal syndrome. Archives of Clinical Neuropsychology, 8, 185-202.

23. Solomon, D.A. & Malloy, P.F. (1993). Alcohol, head injury, and neuropsychological function. Neuropsychology Review, 3, 249-280.

24. Nadler, J.D., Richardson, E.D., Malloy, P.F., Marran, M.E., & Hostetler-Brinson, M. (1993). The ability of the Dementia Rating Scale to predict everyday functioning. Archives of Clinical Neuropsychology, 8, 449-460.

25. Longabaugh, R., Beattie, M., Noel, N. Stout, R., & Malloy, P. (1993). The effect of social investment on alcohol treatment outcome. Journal of Studies on Alcohol, 54, 465-478.

p. 4 of 23

Revised 07/26/2019

26. Nadler, J.D., Richardson, E.D., & Malloy, P.F. (1994). Detection of impairment with the Mini-Mental State Examination. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 7, 109-113.

27. Malloy, P.F. & Richardson, E.D. (1994). The frontal lobes and content-specific delusions. Journal of Neuropsychiatry and Clinical Neuroscience, 6, 455-466.

28. Malloy, P.F. & Richardson, E.D. (1994). Assessment of frontal lobe functions. Journal of Neuropsychiatry and Clinical Neuroscience, 6, 399-410.

29. Salloway, S., Malloy, P.F., & Duffy, J. (1994). The frontal lobes and neuropsychiatric illness. Journal of Neuropsychiatry and Clinical Neuroscience, 6, 341-342.

30. Duffy, J. D., & Malloy, P. F. (1994). Efficacy of buspirone in the treatment of posttraumatic stress disorder: An open trial. Annals of Clinical Psychiatry, 6(1), 33-37.

31. Longabaugh, R., Rubin, A., Malloy, P., Beattie, M., Clifford, P. R., & Noel, N. (1994). Drinking outcomes of alcohol abusers diagnosed as antisocial personality disorder. Alcohol Clin Exp Res, 18(4), 778-785.

32. Richardson, E.D., Nadler, J.D., & Malloy, P.F. (1995). Neuropsychologic prediction of performance measures of daily living skills in geriatric patients. Neuropsychology, 9, 565-572.

33. Coffey, C.E., Cummings, J.L., Duffy, J., Fink, M., Lauterbach, E.C., Lovell, M., Malloy, P.F., Nussbaum, P., Royall, D.R., Salloway, S. (1995). Assessment of treatment outcomes in neuropsychiatry. Journal of Neuropsychiatry and Clinical Neuroscience, 7, 287-289.

34. Nadler, J.D., Grace, J., White, D.A., Butters, M.A., & Malloy, P.F. (1996). Laterality differences in quantitative and qualitative Hooper performance. Archives of Neuropsychology, 11, 223-229.

35. Waldstein, S.R., Malloy, P.F., Stout, R., Longabaugh, R. (1996). Predictors of neuropsychological impairment in alcoholics: Antisocial versus nonantisocial subtypes. Addictive Behaviors, 21, 21-27.

36. Salloway S, Malloy P, Rogg J, Kohn R, Duffy J, Tung G, Thomas C, Richardson E, Gillard E. (1996). MRI and neuropsychological differences in early and late-life onset geriatric depression. Neurology, 46, 1567-1574.

37. Cahn, D.A., Malloy P.F., Salloway S., Rogg J., Gillard, E., Kohn R., Tung G., Richardson E., Westlake, R. (1996). Subcortical hyperintensities on magnetic resonance imaging and activities of daily living in geriatric depression. Journal of Neuropsychiatry and Clinical Neuroscience, 8, 404-411.

38. Paulsen, J.S., Stout, J.C., DelaPena, J., Romero, R., Tawfik-Reedy, Z., Swenson, M.R., Grace, J., & Malloy, P.F. (1996). Frontal behavioral syndromes in cortical and subcortical dementia. Assessment, 3, 327-337.

39. Cloud, B.S., Giovannetti, C.T., Rothenberg, H. Malloy, P.F., & Libon, D.J. (1996). A case of late-onset psychosis: Integrating neuropsychological and SPECT data. Journal of Geriatric Psychiatry and Neurology, 9, 146-153.

40. Jenkins, M.A., Cimino, C., Malloy, P.F., Salloway, S., Cohen, R., Kohn, R., & Westlake, R. (1997). Neuropsychiatric factors in the 'Illusion of Visitors' among geriatric patients: A case series. Journal of Geriatric Psychiatry and Neurology, 10, 79-87.

41. Harrington, C., Salloway, S., & Malloy, P.F. (1997). Dramatic behavioral disorder in two cases following bilateral anteromedial frontal lobe injury: Delayed psychosis and marked change in personality. Neurocase, 3, 137-149.

42. Malloy, P.F., Cummings, J.L., Coffey, C.E., et al. (1997). Cognitive screening instruments in neuropsychiatry: A report of the Committee on Research of the American Neuropsychiatric Association. Journal of Neuropsychiatry & Clinical Neuroscience, 9, 189-197.

43. Mega, M.S., Cummings, J.L., Salloway, S., & Malloy, P.F. (1997). The limbic system: An anatomic, phylogenic, and clinical perspective. Journal of Neuropsychiatry & Clinical Neuroscience, 9, 315-330.

p. 5 of 23

Revised 07/26/2019

44. Jenkins, M.A., Malloy, P.F., Salloway, S., Cohen, R., Rogg, J., Tung, G, Kohn, R., Westlake, R., Johnson, E.G., Richardson, E. (1998). Memory processes in depressed geriatric patients with and without subcortical hyperintensities on MRI. Journal of Neuroimaging, 8, 20-26.

45. Jenkins, M.A., Cohen, R., Malloy, P.F., Salloway, S., Johnson, E.G., Penn, J., and Marcotte, A. (1998). Neuropsychological measures which discriminate among adults with residual symptoms of Attention Deficit Disorder and other attentional complaints. The Clinical Neuropsychologist, 12, 74-83.

46. Lukatela, K., Malloy, P.F., Jenkins, M., & Cohen, R. (1998). The naming deficit in early Alzheimer's and vascular dementia. Neuropsychology, 12, 565-572.

47. Cummings, J.L., Coffey, C.E., Duffy, J.D., Lauterbach, E.C., Lovell, M., Malloy, P.F., Royall, D.R., Rummans, T.A., & Salloway, S. (1998). The clinician-scientist in neuropsychiatry: A position statement from the Committee on Research of the American Neuropsychiatric Association. Journal of Neuropsychiatry and Clinical Neuroscience, 10, 1-9.

48. Malloy, P.F., & Aloia, M. (1998). Frontal lobe dysfunction in traumatic brain injury. Seminars in Clinical Neuropsychiatry, 3, 186-194.

49. Lauterbach, E. C., Cummings, J. L., Duffy, J., Coffey, C. E., Kaufer, D., Lovell, M., Malloy, P., Reeve, A., Royall, D. R., Rummans, T. A., & Salloway, S. P. (1998). Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. Journal of Neuropsychiatry and Clinical Neuroscience, 10(3), 249-266.

50. Moser, D. J., Cohen, R. A., Malloy, P. F., Stone, W. M., & Rogg, J. M. (1998). Reduplicative paramnesia: A longitudinal neurobehavioral and neuroimaging analysis. Journal of Geriatric Psychiatry and Neurology 11, 174-180.

51. Grace, J., Stout, J.C. & Malloy, P.F., (1999). Assessing frontal behavioral syndromes with the Frontal Lobe Personality Scale. Assessment, 6, 269-284.

52. Paul, R.H., Piatt, A.L., Whelihan, W.M. & Malloy, P.F. (2000). Neuropsychological and magnetic resonance abnormalities associated with a plasmacytoma of the frontal dura: A case report. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 13, 143-147.

53. Cahn-Weiner, D., Malloy, P.F., Boyle, P., Marran, M. & Salloway, S. (2000). Prediction of functional status from neuropsychological tests in community-dwelling elderly individuals. The Clinical Neuropsychologist, 14, 187-195.

54. Norton, L., Malloy, P.F., & Salloway, S. (2001). The impact of behavioral symptomology on activities of daily living in patients with dementia. American Journal of Geriatric Psychiatry,9, 1-8.

55. Salloway, S., Boyle, P. A., Correia, S., Malloy, P. F., Cahn-Weiner, D. A., Schneider, L., et al. (2002). The relationship of MRI subcortical hyperintensities to treatment response in a trial of sertraline in geriatric depressed outpatients. Am J Geriatr Psychiatry, 10(1), 107-111.

56. Cahn-Weiner, D.A., Boyle, P.A., & Malloy, P.F. (2002). Tests of executive function predict instrumental activities of daily living in community-dwelling older individuals. Applied Neuropsychology, 3, 187-191.

57. Rymer, S., Salloway, S. Norton, E., Malloy, P.F., Correia, S., Monast, D. (2002). Awareness of deficit, behavioral disturbance, and caregiver burden in Alzheimer’s disease. Alzheimer Disease and Associated Disorders, 6, 248-253.

58. Salloway, S., Correia, S., Boyle, P., Malloy, P., Schneider, L., Lavretsky, H., Sackheim, H., Roose, S., Ranga Rama Krishnan, K. (2002). MRI subcortical hyperintensities in old and very old depressed outpatients: The important role of age in late-life depression. Journal of the Neurological Sciences, 203, 227-233.

59. Stout, J., Ready, R., Grace, J., Malloy, P.F., Paulsen, J.S. (2003). Factor analysis of the Frontal Systems Behavior Scale. Assessment, 10, 1-7.

p. 6 of 23

Revised 07/26/2019

60. Boyle, P.A., Malloy, P.F., Salloway, S., Cahn-Weiner, D.A., Cohen, R., Cummings, J.L. (2003). Executive dysfunction and apathy predict functional impairment in Alzheimer’s disease. American Journal of Geriatric Psychiatry, 11, 214-221.

61. Cahn-Weiner, D.A., Malloy, P.F., Rebok, G., & Ott, B. (2003). Results of a randomized placebo-controlled study of memory training for mildly impaired Alzheimer’s disease patients. Applied Neuropsychology, 10, 215-223.

62. Cahn-Weiner, D.A., Ready, R.E., and Malloy, P.F. (2003). Neuropsychological predictors of everyday memory and everyday functioning in patients with mild Alzheimer’s disease. Journal of Geriatric Psychiatry and Neurology, 16, 84-89.

63. Paul, R.H., Cohen, R.A., Moser, D.J., Ott, B.R., Sweet, L., Browndyke, J., Malloy, P., & Garrett, K. (2003). Clinical correlates of cognitive decline in vascular dementia. Cognitive and Behavioral Neurology, 16, 40-46.

64. Malloy, P.F., Belanger, H., Hall, S., Aloia, M., & Salloway, S. (2003). Assessing visuoconstructional performance in Alzheimer’s disease, mild cognitive impairment and normal elderly using the Beery Visual-Motor Integration Test. The Clinical Neuropsychologist, 17, 544-550.

65. Boyle, P. A., & Malloy, P.F. (2004). Treating apathy in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 17, 91-9.

66. Davis Garrett, K., Cohen, R. A., Paul, R. H., Moser, D. J., Malloy, P. F., Shah, P., et al. (2004). Computer-mediated measurement and subjective ratings of white matter hyperintensities in vascular dementia: Relationships to neuropsychological performance. The Clinical Neuropsychologist, 18(1), 50-62.

67. Malloy, P.F. & Grace, J. (2005). A review of rating scales for measuring behavior change due to frontal systems damage. Cognitive and Behavioral Neurology, 18, 18-27.

68. Belanger, H.C., Wilder-Willis, K., Malloy, P.F., Grigsby, J., Salloway, S. (2005). The Behavioral Dyscontrol Scale in mild cognitive impairment and Alzheimer’s disease. Archives of Clinical Neuropsychology, 20, 183-189.

69. Friend, K., Malloy, P.F. (2005). The effects of chronic nicotine and alcohol use on neurocognitive function. Addictive Behavior, 30, 193-202.

70. Jones, R. N., Rosenberg, A., Morris, J., Allaire, J., McCoy, K., Kleinman, K., Rebok, G., Malloy, P., & Marsiske, M. (2005). A growth curve model of learning acquisition among cognitively normal older adults. Experimental Aging Research., 31, 291–312.

71. Paul, R., Flanigan, T., Navia, B., Makris, N., Hinkin, C., Malloy, P.F., Jefferson, A., Cohen, R.A., Tate, D., Brickman, A.M. (2005). Apathy is associated with volume of the nucleus accumbens in patients infected with HIV. Journal of Neuropsychiatry and Clinical Neuroscience, 17, 167-171.

72. Greenberg, B.D., Malone, D.A., Friehs, G.M., Rezai, A.R., Kubu, C.S., Malloy, P.F., Salloway, S.P., Okun, M.S., Goodman, W.K. Rasmussen, S.A. (2006). Three-year outcomes in deep brain stimulation for highly resistant obsessive-compulsive disorder. Neuropsychopharmacology. 1-10.

73. Malloy, P.F., Correia, S., Stebbins, G., & Laidlaw, D. (2007). Neuroimaging of white matter in aging and dementia. The Clinical Neuropsychologist, 21, 1-38.

74. Laidlaw, D., Lee, S., Correia, S., Tate, D., Paul, R., Zhang, S., Salloway, S., and Malloy, P. (2007). Quantitative tract-of-interest metrics for white matter integrity based on diffusion tensor MRI data. Views Radiology, 8, 2-4.

75. Grant, J.E., Correia, S., Brennan-Krohn, T., Malloy, P.F., & Schulz, S.C. (2007) Frontal white matter integrity in Borderline Personality Disorder with self-injurious behavior. Journal of Neuropsychiatry and Clinical Neuroscience, 19, 383-390.

76. Malloy, P., Tremont, G., Grace, J., & Frakey, L. (2007). The Frontal Systems Behavior Scale discriminates frontotemporal dementia from Alzheimer's disease. Alzheimers Dement, 3(3), 200-203.

p. 7 of 23

Revised 07/26/2019

77. Williams, V. G., Bruce, J. M., Westervelt, H. J., Davis, J. D., Grace, J., Malloy, P. F., Tremont, G. (2007). Boston naming performance distinguishes between Lewy body and Alzheimer's dementias. Archives of Clinical Neuropsychology, 22, 925-932.

78. Royall, D., Lauterbach, E.C., Kaufer, D., Malloy, P., Coburn, K.L., Black, K. J. (2007). The cognitive correlates of functional status: A review from the Committee on Research of the American Neuropsychiatric Association. Journal of Neuropsychiatry and Clinical Neuroscience, 19, 249–265.

79. Correia, S., Lee, S., Voom, T., Tate, D., Paul, R., Zhang, S., Salloway, S., Malloy, P., Laidlaw, D. (2008) Quantitative tract-of-interest metrics for white matter integrity based on diffusion tensor MRI data. NeuroImage, 48, 568-581.

80. Malone, D.A. Jr, Dougherty D.D., Reza, A.R., et al. (2009). Deep brain stimulation of the ventral capsule / ventral striatum for treatment resistant depression. Biological Psychiatry, 65, 267-275.

81. Malloy, P., McLaughlin, N. C., Epstein-Lubow, G., Doughty, A., Marino, L., & Milner, M. (2010). The Severe Impairment Battery predicts functional abilities in an inpatient geriatric population. Applied Neuropsychology, 17(3), 172-176.

82. Greenberg, B.D., Gabriels, L.A., Malone, D.A. et al. (2010). Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: Worldwide experience. Molecular Psychiatry, 15, 64-79.

83. McLaughlin, N., Chang, A.C., and Malloy, P.F. (2010). Verbal and non-verbal learning and recall in Dementia with Lewy Bodies and Alzheimer’s Disease. Applied Neuropsychology, 17, 172-176.

84. Wolk, D. A., Dickerson, B. C., Weiner, M., et al (2010). Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proceedings of the National Academy of Sciences. 107 (22), 10256-10261

85. Frakey, L., Salloway, S., Buelow, M., and Malloy, P.F. (2012). A double blind study of modafinil for the treatment of apathy in individuals with Alzheimer’s disease. Journal of Clinical Psychiatry, 73, 796-801.

86. Bakken TE, Roddey JC, Djurovic S, et al (2012). Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proc Natl Acad Sci USA. 2012 Mar 6;109(10):3985-90. doi: 10.1073/pnas.1105829109. Epub 2012 Feb 16. PMID: 22343285

87. Mikos, A., Piryatinsky, I., Tremont, G., and Malloy. P.F. (2013). The APOE4 allele is associated with increased frontally-mediated neurobehavioral symptoms in amnestic MCI. Alzheimer Disease & Associated Disorders, 27, 109-113.

88. Kubu, C.S., Malone, D.A., Chelune, G., Malloy, P.F., Rezai, A.R., Frazier, T., Machado, A., Rasmussen, S., Friehs, G., Greenberg, B. (2013). Neuropsychological outcome after deep brain stimulation in the ventral capsule/ventral striatum for highly refractory OCD or Major Depression. Journal of Stereotaxic and Functional Neurosurgery, 91, 374-378.

89. Carvalho, J. Ready, R.E., Malloy, P.F. and Grace, J. (2013). Confirmatory factor analysis of the Frontal Systems Behavior Scale (FrSBe). Assessment, 20, 632-641.

90. Bryant, V.E., Whitehead, N.E., Burrell, L.E., II., Dotson, V.M., Cook, R.L., Malloy, P., Devlin, K., Cohen, R.A. (2014). Depression and apathy among people living with HIV: Implications for treatment of HIV Associated Neurocognitive Disorders. AIDS and Behavior, 19, 1430-1437.

91. Correia, S., Ahern, D.C., Rabinowitz, A.R., Farrer, T.J., Smith-Watts, A.K., Salloway, S., Malloy, P.F., Deoni, S. (2015). Lowering the floor on Trail Making Test – Part B: Psychometric evidence for a new scoring metric. Archives of Clinical Neuropsychology, 30, 643-56.

92. Rossetti, MA, Piryatinsky, I, Fayeza, SA, et al (2016). Two novel psychomotor tasks in idiopathic normal pressure hydrocephalus. Journal of the International Neuropsychological Society, 22, 341-349.

93. Kubu, C.S., Brelje, T., Butters, M., Deckersbach, T., Malloy, P.F. et al. (2016). Cognitive outcome after ventral capsule/ventral striatum stimulation for treatment-resistant major depression. Journal of Neurology, Neurosurgery and Psychiatry, 88, 262-265.

p. 8 of 23

Revised 07/26/2019

94. McLaughlin NCR, Nanda P, Banks GP, Miguel EC, Sheehan J, Lopes AC, et al. (2017). Gamma knife capsulotomy for intractable OCD: Impact of lesion size and location. Biological Psychiatry, 81:S276.

95. Rasmussen S.A, Norén G., Greenberg B., Marsland R., McLaughlin N., Malloy P., Salloway S., Strong D., Eisen J., Jenike M., Rauch S.L., Baer L. & Lindquist C. (2018). Gamma ventral capsulotomy in intractable obsessive-compulsive disorder, Biological Psychiatry, 84, 355-364.

96. Chapman KR, Tremont G, Malloy P, Spitznagel MB (2019). Identification of sexual disinhibition in dementia by family caregivers. Alzheimer Disease & Associated Disorders, 33, 154-159.

97. Chapman KR, Tremont G, Malloy P, Spitznagel MB (2020). The role of sexual disinhibition to predict caregiver burden and desire to institutionalize among family dementia caregivers. Journal of Geriatric Psychiatry and Neurology, 33, 42-51.

98. Asken, BM, Thomas, KR, Lee, A, Davis, JD, Malloy, PF, Salloway, SP, Correia, S (in press). Discrepancy-based evidence for loss of thinking abilities (DELTA): Development and validation of a novel approach to identifying cognitive changes. Journal of the International Neuropsychological Society.

99. Alsemari, A and Malloy, PF. (in press). The Behavioral Dyscontrol Scale in the differential diagnosis of behavioral variant of Frontotemporal Dementia and Alzheimer Disease. The Clinical Neuropsychologist DOI: 10.1080/13854046.2019.1701709

Other peer-reviewed publications: 1. Malloy, P.F. (1999). Web alert: Neuropsychiatry. Current Psychiatry Reports, 1, 3-4. Books and book chapters: 1. Levis, D. J. & Malloy, P. F. (1982). Experimental foundations of behavior therapy: Animal and

human conditioning research. In G. T. Wilson & C. M. Franks (Eds.), Contemporary behavior therapy: Conceptual foundations of clinical practice. New York: Guilford Press.

2. Malloy, P. F. & Alfred, G. S. (1985). Fundamentals of behavior therapy. In M. Hersen (Ed.), Pharmacological and behavioral treatment. New York: John Wiley, pp.49-87.

3. Malloy, P. F. & Nadeau, S. (1986). The neurological examination and related procedures in behavioral neurology and neuropsychology. In D. Wedding, A.M. Horton, and J. Webster (Eds.), The neuropsychology handbook: Behavioral and clinical perspectives. New York: Springer, pp. 105-133.

4. Malloy, P. F. (1987). Frontal lobe dysfunction in obsessive-compulsive disorder: Evidence from evoked potential mapping and neuropsychological tests. In E. Perecman, (Ed.), The frontal lobes revisited. New York: IRBN Press, pp. 207-223.

5. Malloy, P.F. (1992). Risk factors for neuroradiological and neuropsychological abnormalities in alcoholism: Review and presentation of a model. In P. Nathan & J. Langenbucker (Eds.), Annual Review of Addictions Research and Treatment. New York: Pergamon Press, pp. 61-80.

6. Malloy, P.F. & Duffy, J. (1994). The frontal lobes in neuropsychiatric disorder. In F. Boller & J. Grafman (Eds.), Handbook of Neuropsychology (Vol. 9), 203-232.

7. Malloy, P.F., Cohen, R., & Jenkins, M. (1999). Frontal lobe function and dysfunction. In P. D. Nussbaum & P. Snyder (Eds.), Clinical Neuropsychology: A Pocket Handbook for Assessment. American Psychological Association.

8. Cohen, R., Malloy, P.F., & Jenkins, M.(1999). Disorders of attention. In P. D. Nussbaum & P. Snyder (Eds.), Clinical Neuropsychology Practice Guidebook. American Psychological Association.

9. Salloway, S., Malloy, P. F., & Cummings, J. L. (Eds.) (1997). The neuropsychiatry of limbic and subcortical disorders. Washington: American Psychiatric Press, Inc.

10. Mega, M. S., Cummings, J. L., Salloway, S., & Malloy, P.F. (1997). The limbic system: An anatomic, phylogenetic, and clinical perspective. In Salloway, S., Malloy, P. F., & Cummings, J. L. (Eds.)

p. 9 of 23

Revised 07/26/2019

(1997). The neuropsychiatry of limbic and subcortical disorders. Washington: American Psychiatric Press, Inc., pp. 3-18.

11. Malloy, P.F. & Richardson, E.D. (2001). Assessment of frontal lobe functions. In Salloway, S., Malloy, P. F., Duffy, J. (Eds.). The frontal lobes and neuropsychiatric disorders. Washington: American Psychiatric Press, Inc.

12. Richardson, E.D. & Malloy, P.F. (2001). The frontal lobes and content-specific delusions. In Salloway, S., Malloy, P. F., Duffy, J. (Eds.) The frontal lobes and neuropsychiatric illness. Washington: American Psychiatric Press, Inc.

13. Salloway S, Malloy P, Duffy J. (2001). The frontal lobes and neuropsychiatric illness. American Psychiatric Press Inc., Washington, D.C.

14. Grace, J. & Malloy, P.F. (2002). The Frontal Systems Behavior Scale (FrSBe). Psychological Assessment Resources, Odessa, FL.

15. Malloy, P.F. & McLaughlin, N.C.R. (2010). Everyday functioning in dementia and mild cognitive impairment. In T. Marcotte and I. Grant, Neuropsychology of Everyday Functioning. Guilford Press.

16. Malloy, P.F. (2011). Associate Editor, Frontal and executive functions, Encyclopedia of Clinical Neuropsychology, New York: Springer.

17. Malloy, P.F. (2011). Capgras syndrome, in Encyclopedia of Clinical Neuropsychology, New York: Springer, pp. 484-487.

18. Malloy, P.F. (2011). Reduplicative paramnesia, in Encyclopedia of Clinical Neuropsychology, New York: Springer, pp. 2131-2133.

19. Malloy, P.F. (2011). Prefrontal cortex, in Encyclopedia of Clinical Neuropsychology, New York: Springer, pp. 1998-2001.

20. Malloy, P.F. (2011). Dorsolateral frontal system, in Encyclopedia of Clinical Neuropsychology, New York: Springer, pp. 888-892.

21. Malloy, P.F. (2011). Delayed response tasks, in Encyclopedia of Clinical Neuropsychology, New York: Springer, pp. 789-791.

22. Cohen, R., Malloy, P.F., Jenkins, M., & Paul, R. (2014). Disorders of attention. In Michael Parsons (Ed.), Clinical Neuropsychology Guidebook. American Psychological Association.

23. Domoto-Reilly, K., Malloy, P.F., Cahn-Weiner, D., Brown, T.M. (2015). Frontal systems and dysfunctions. In Psychiatric Care of the Medical Patient (B. Fogel and D. Greenberg, Eds.).

Abstracts: 1. Malloy. P.F., Cimino, C., & Westlake, R. (1990). An unusual reduplicative phenomenon. Archives of

Clinical Neuropsychology, 5, 189 (Abstract). 2. Malloy, P.F., Nadler, J.D., Butters, M.A., Mutchnick, M.G., Richardson, E.D. (1991).

Neuropsychological aspects of content-specific delusions. Neurology, 41, 120 (abstract). 3. Nadler, J.D., Richardson, E.D., & Malloy, P.F. (1992). Limitations of the MMSE with high scoring

patients. The Clinical Neuropsychologist (abstract). 4. Richardson, E.D., McCartney, J., Fiore, T., Carpenter, C., Emmons, K., Niaura, R., & Malloy, P.F.

(1992). Neuropsychological functioning in HIV seropositive female polydrug abusers. The Clinical Neuropsychologist, 6, 343 (abstract).

5. Malloy, P.F. & Richardson, E.D. (1993). The neuropsychology of content-specific delusions. Journal of Neuropsychiatry and Clinical Neurosciences, 5, 454 (abstract).

6. Malloy, P.F., Salloway, S., Rogg, J., Kohn, R., & Thomas, C. (1994). Clinical significance of subcortical encephalomalacia in early- and late-life onset depression. Neurology, 44, 375 (abstract).

7. Grace, J., Malloy, P.F., Stout, J.C. (1997). Quantitative assessment of frontal apathy: A case study utilizing the Frontal Lobe Personality Scale. Journal of Neuropsychiatry & Clinical Neuroscience, 9, 672 (abstract).

p. 10 of 23

Revised 07/26/2019

8. Grace, J., Malloy, P.F., Stout, J.C. (1997). Assessing frontal behavioral syndromes: Reliability and validity of the Frontal Lobe Personality Scale. Archives of Clinical Neuropsychology, 12, 327 (abstract).

9. Moser, D. J., Cohen, R. A., Malloy, P. F., Stone, W. M., & Rogg, J. M.. (1999). Reduplicative paramnesia: A neuroimaging and neurobehavioral case analysis. Journal of the International Neuropsychological Society, 5, 152 (abstract).

10. Malloy P, Rymer S, Salloway S, Norton, L (2002). Contributions to caregiver burden in Alzheimer’s disease: awareness of deficit and behavioral disturbance. Neurobiology of Aging;23(1S):S159.

11. Correia S, Salloway S, Boyle P, Malloy P, Cahn-Weiner D, Scheider L, Krishnan RR, Nakra R. Relationship of subcortical hyperintensities to treatment response in young and old elderly with outpatient geriatric depression: Results of two placebo-controlled trials. Neurobiology of Aging 2002;23(1S):S159.

12. Boyle P, Malloy P, Salloway S, Correia S. Functional significance of subcortical white matter changes in Alzheimer’s disease. Neurobiology of Aging 2002; 23(1S):S495.

13. Correia, S., Song Zhang, S. Laidlaw, D., Malloy, P., Salloway, S. (2004). Diffusion-tensor imaging: linear, planar, and spherical diffusion in CADASIL. Neurobiology of Aging, 25, S298.

14. Correia, S., Salloway, S., Malloy, P., Song, C., Li, R. (2004). Systolic blood pressure variability and subcortical hyperintensities in patients with mild-to-moderate Alzheimer's disease. Neurobiology of Aging, 25, S278–S279.

15. Boyle, P., Malloy, P., O’Connor, M., Carruth, S., Green, R.C. (2004). Evaluating the efficacy of a caregiver-based, behavioral intervention for reducing neuropsychiatric symptoms among patients with Alzheimer's disease and for reducing caregiver distress: a controlled trial. Neurobiology of Aging, 25, S329.

16. Stephen Correia, David H. Laidlaw, David Tate, Stephanie Lee, Thom Voorn, Robert Paul, Song Zhang, Steven Salloway, and Paul Malloy (2008). Quantitative Tractography Metrics of White Matter Integrity in Diffusion Tensor MRI. Neuroimage.

17. Lee, A., Rao, J., van Hulden, S, … Malloy, P. (2013). Myelin integrity, cognitive function and hypertension in MCI and Alzheimer's disease. Alzheimer's and Dementia 9(4):P275-P276

Presentations and invited addresses

Presentations 1. Twentyman, C. T., Malloy, P. F., & Green, A. S. Instructed heart rate control in a tachycardia analog

population. Paper presented at the annual meeting of the Society for Psychophysiological Research, 1978.

2. Stefen, C. & Malloy, P. F. Validation of a test of schizophrenic thought disorder. Paper presented at annual meeting of Psychologists in New York State Service, 1978.

3. Hare, N. & Malloy, P. F. Faschinbauer MMPI scales predicting length of stay, type of discharge, and recidivism in psychiatric patients. Paper presented at the annual meeting of the Eastern Psychological Association, 1979.

4. Malloy, P. F. & Levis, D. J. A conditioning model of human psychopathology: Laboratory evidence. Paper presented at the annual meeting for the Association for the Advancement of Behavior Therapy, 1980.

5. Malloy, P. F. & Webster, J. S. Differential diagnosis of "borderline" neurological patients using the Luria-Nebraska Neuropsychological Battery. Paper presented at the annual meeting of the Association for the Advancement of Behavior Therapy, 1980.

6. Webster, J. S., Dostrow, V., McNeer, M. F., & Malloy, P. F. A hierarchical approach to Luria's neuropsychological assessment. Paper presented at the annual meeting of the Association for the Advancement of Behavior Therapy, 1980.

7. Malloy, P. F., Fairbank, J. A. & Keane, T. M. Tripartite assessment of posttraumatic stress disorder. Paper presented at the annual meeting of the American Psychological Association, 1982.

p. 11 of 23

Revised 07/26/2019

8. Fairbank, J. A., Keane, T. M., & Malloy, P. F. Demographic and psychological characteristics of Vietnam veterans with posttraumatic stress. Paper presented at the annual meeting of the American Psychological Association, 1982.

9. Malloy, P. F., Keane, T. M., & Fairbank, J. A. Validating a behavioral assessment methodology for posttraumatic stress disorders in Vietnam veterans. Paper presented at the annual meeting of the Association for the Advancement of Behavior Therapy, 1982.

10. Malloy, P. F. & Webster, J. S. A test of Luria's frontal lobe syndromes. Paper presented at the annual meeting of the American Psychological Association, 1982.

11. Fairbank, J. A., Keane, T. M., & Malloy, P. F. Psychological characteristics of Vietnam veterans with and without posttraumatic stress disorders. Paper presented at the annual meeting of the Southeastern Psychological Association, 1983.

12. Carstensen, L.. & Malloy, P. F. Neuropsychological status of socially withdrawn nursing home patients. Paper presented at the annual meeting of the Gerontological Society of America, Chicago, 1986.

13. Carstensen, L. L., Fisher, J. E., & Malloy, P. F. Increasing rates of social interaction among elderly nursing home residents. Paper presented at the annual meeting of the American Psychological Association, 1986.

14. Knight, J., Webster, J., Goestch, V., Malloy, P. & Grebe, K. Utilizing the Wisconsin Card Sorting Test to detect malingering performances. Paper presented at the annual meeting of the American Psychological Association, 1986.

15. Rogers, S., Malloy, P. F., Noel, N., Longabaugh, R., & Beatty, M. Risk factors for neuropsychological impairment in alcoholics. Paper presented at the annual meeting of the American Psychological Association, 1986.

16. Kohn, R., Lilly, R. B., Sokol, M.S., & Malloy, P. F. Psychiatric presentations of intracranial cysts. Paper presented at the annual meeting of the American Academy of Neurology, 1988.

17. Malloy, P. F., Noel, N., Longabaugh, R., & Beattie, M. Antisocial personality disorder and neuropsychological impairment in alcohol abusers. Paper presented at the annual meeting of the American Psychological Association, Atlanta, 1988.

18. Longabaugh, R., Malloy, P. F., Noel, N., Beattie, M., & Stout, R. Antisocial personality, neuropsychological impairment, and treatment outcome. Paper presented at the annual meeting of the American Psychological Association, Atlanta, 1988.

19. Longabaugh, R., Beattie, M., Noel, N., Stout, R., & Malloy, P. Matching treatments to patients. Paper presented at the Research Institute on Alcoholism, Buffalo, 1988.

20. Malloy, P. F., Noel, N., Longabaugh, R., Beattie, M., & Stout, R. Neuropsychology and alcohol treatment outcome. Paper presented at the annual meeting of the Association for the Advancement of Behavior Therapy, New York, 1988.

21. Malloy, P. F., Cimino, C., & Westlake, R. An unusual reduplicative delusion. Paper presented at the annual meeting of the National Academy of Neuropsychology, Washington, 1989.

22. Malloy, P.F. Neuropsychology and occupational therapy in geriatric guardianship decisions. Paper presented at the annual meeting of the American Psychiatric Association, New York, 1990.

23. Longabaugh, R., Beattie, M., Noel, N., Stout, R., & Malloy, P. F. Matching alcoholic patients to relationally-focused treatments. Paper presented at the annual meeting of the American Psychological Association, Boston, 1990.

24. Malloy, P.F., Nadler, J.D., Butters, M.A., Mutchnik, M.G., & Richardson, E.D. Neuropsychological aspects of content-specific delusions. Paper presented at the annual meeting of the American Academy of Neurology, Boston, 1991.

25. Nadler, J.D., Butters, M.A., Richardson, E.D. & Malloy, P.F. Qualitative errors in verbal fluency performance between dementias with anterior and posterior features. Paper presented at the annual meeting of the International Neuropsychological Society, San Diego, 1992.

26. Nadler, J.D., Richardson, E.D., & Malloy, P.F.. Limitations of the MMSE with high scoring patients. Paper presented at the annual meeting of the American Psychological Association, Washington, 1992.

p. 12 of 23

Revised 07/26/2019

27. Richardson, E.D., McCartney, J., Fiore, T., Carpenter, C., Niaura, R., Emmons, K., & Malloy, P.F. Neuropsychological functioning in HIV seropositive female polydrug abusers. Paper presented at the annual meeting of the American Psychological Association, Washington, 1992.

28. Malloy, P.F. & Richardson, E. Neuropsychology of content-specific delusions. Paper presented at the annual meeting of the American Neuropsychiatric Association, San Antonio, TX, March, 1993.

29. Salloway, S., Malloy, P.F., Rogg, J., Duffy, J., Kohn, R. T2 hyperintensities on MRI in late-life onset depression. Paper presented at the annual meeting of the American Neuropsychiatric Association, San Antonio, TX, March, 1993.

30. Nadler, J., Richardson, E., Malloy, P.F., J., Duffy. Detection of dementia with the Mini-Mental State. Paper presented at the annual meeting of the American Neuropsychiatric Association, San Antonio, TX, March, 1993.

31. Malloy, P.F. & Richardson, E. The frontal lobes and delusions. Paper presented at the annual meeting of the American Psychiatric Association, San Francisco, CA, May, 1993.

32. Waldstein, S., Malloy, P.F., & Stout, R. Neuropsychological performance among antisocial and non-antisocial alcoholics. Paper presented at the annual meeting of the International Neuropsychological Society, Cincinnati, OH, February, 1994.

33. Malloy, P.F., Salloway, S., Rogg, J., Kohn, R., & Gillard, E. Clinical Significance of subcortical encephalomalacia in late-life onset depression. Paper presented at the annual meeting of the American Psychiatric Association, Philadelphia, PA, May, 1994.

34. Malloy, P.F. & Salloway, S.P. Reduplicative paramnesia following a lacunar infarct in the genu of the right internal capsule. Paper presented at the annual meeting of the American Neuropsychiatric Association, Newport, RI, July, 1994.

35. Dammers, P.M., Bolter, J.F., Gouvier, W.D., Malloy, P.F., Adams, S.G., Morrison, M.W., Proctor, L.A., Robertson, J.M. Patterns of adaptive functioning among prototypical subcortical and cortical pathology groups. Paper presented at the annual meeting of the American Neuropsychiatric Association, Newport, RI, July, 1994.

36. Gillard, E., Malloy, P.F., & McCartney, J. Comparison of the MMSE and CCSE in a geriatric population. Paper presented at the annual meeting of the National Academy of Neuropsychology, Orlando, FL, November, 1994.

37. Malloy, P.F. Morales. X., Salloway, S., & Richardson, E. Sexual delusions: A case series. Paper presented at the annual meeting of the American Neuropsychiatric Association, Pittsburgh, 1995.

38. Coffey, C.E., Malloy, P.F., Cummings, J.L., Duffy, J.D., Fink. M., Lauterbach, E.C., Lovell, M.L., Royall, D.R., Salloway, S. Clinical outcomes in neuropsychiatry: Assessment of cognitive status. Paper presented at the annual meeting of the American Neuropsychiatric Association, Pittsburgh, 1995.

39. Chang, K., Neeper, R., Jenkins, M., Penn, J., Bollivar, L., Israeli, L., Malloy, P., Salloway, S. Clinical profiles of patients referred for evaluation of adult attention deficit/hyperactivity disorder. Paper presented at the annual meeting of the American Neuropsychiatric Association, Pittsburgh, 1995.

40. Cloud, B.S., Giovannetti, C.T., Malloy, P.F., & Libon, D.J. Neuropsychological and SPECT analysis of a content-specific delusional syndrome. Paper presented at the annual meeting of the American Neuropsychiatric Association, Pittsburgh, 1995.

41. Jenkins, M., Malloy, P.F., Salloway, S., & Biber, M. Aphasia and delusions as primary symptoms in a case of multiple sclerosis. Paper presented at the annual meeting of the American Neuropsychiatric Association, Pittsburgh, 1995.

42. Salloway, S., Rasmussen, S., & Malloy, P.F. Resolution of long-standing obsessive-compulsive disorder following left anteromedial thalamic infarction. Paper presented at the annual meeting of the American Neuropsychiatric Association, Pittsburgh, 1995

43. Grace,J., Malloy, P.F. & Stout, J. Assessing frontal behavioral syndromes. Paper presented at the annual meeting of the National Academy of Neuropsychology, New Orleans, November, 1996.

p. 13 of 23

Revised 07/26/2019

44. Grace, J, Malloy, P.F., Stout, J.C. Quantitative assessment of frontal apathy: A case study utilizing the Frontal Lobe Personality Scale. Paper presented at the annual meeting of the American Neuropsychiatric Association, Honolulu, 1997.

45. R.N. Jones, K. Kleinman, J. Allaire, P. Malloy, A. Rosenberg, J.N., Morris, M. Marsiske. Individual differences in memory function among older adults. Paper presented at the annual meeting of the Geriatric Society of America, Chicago, 2001.

46. Grace, J. & Malloy, P.F. The Frontal Systems Behavior Scale (FrSBe). Workshop presented at the Annual Meeting of the National Academy of Neuropsychology, San Francisco, 2001.

47. Malloy, P.F., and Grace, J. Normative data for the Frontal Lobe Personality Scale (FLOPS). Paper presented at the annual meeting of the International Neuropsychological Society, Chicago, 2001.

48. Malloy, P.F. Novel approaches to investigating frontal systems functioning across the lifespan. Discussant of symposium presented at the annual meeting of the International Neuropsychological Society, Chicago, 2001.

49. Malloy, P.F., Recupero, P., Price, M. Mental capacity: Proving your case. Continuing education workshop presented to the Rhode Island Bar Association, Providence, 2001.

50. Malloy P, Rymer S, Salloway S, Lauren Norton. Contributions to caregiver burden in Alzheimer’s disease: awareness of deficit and behavioral disturbance. Presented at the World Alzheimer Congress, Stockholm, Sweden, July 2002.

51. Correia S, Salloway S, Boyle P, Malloy P, Cahn-Weiner D, Scheider L, Krishnan RR, Nakra R. Relationship of subcortical hyperintensities to treatment response in young and old elderly with outpatient geriatric depression: Results of two placebo-controlled trials. Presented at the World Alzheimer Congress, Stockholm, Sweden, July 2002.

52. Boyle P, Malloy P, Salloway S, Correia S. Functional significance of subcortical white matter changes in Alzheimer’s disease. Presented at the World Alzheimer Congress, Stockholm, Sweden, July 2002.

53. Correia, S., Salloway, S., Belanger, H., Nassery, S., Malloy, P., Drodge, S. Ambulatory blood pressure monitoring in Alzheimer’s Disease patients with high and low degree of subcortical hyperintensities. Presented at the First Congress of the International Society for Vascular Cognitive and Behavioral Disorders, Gothenberg, Sweden, August, 2003.

54. Malloy, P.F. Assessing frontal systems behavior change: Beyond cognitive measures. Paper presented at the annual meeting of the International Neuropsychological Association, Baltimore, MD, February 2004.

55. Wilder-Willis, K., Malloy, P.F., Salloway, S., Correia, S., Belanger, H., Kumariah, D., Flynn-O’Brien, K. Performance on delayed response and delayed matching-to-sample in patients with mild cognitive impairment and normal controls. Paper presented at the annual meeting of the International Neuropsychological Association, Baltimore, MD, February 2004.

56. Wilder-Willis, K.E., Malloy, P.F., Salloway, S., Correia, S., Belanger, H.G., Kumariah, D., & Flynn-O’Brien, K. Performance on experimental measures of working memory and traditional neuropsychological measures of executive functioning in Mild Cognitive Impairment. Paper presented at the annual meeting of the International Neuropsychological Association, Baltimore, MD, February 2004.

57. Malloy, P.F., Belanger, H., Hall, S., Grigsby, J., Wilder-Willis, K., Hamman, R.F., Aloia, M., Salloway, S. Validation of measures of spatial and executive abilities in Alzheimer’s disease (AD) and mild cognitive impairment (MCI). Paper presented at the 9th International Conference on Alzheimer’s Disease and Related Disorders, Philadelphia, 2004.

58. Kubo, C.S., Malone, D., Greenberg, B., Rasmussen, R., Malloy, P.F., Rezai, A.R. Neuropsychological outcome following deep brain stimulation for Obsessive Compulsive Disorder. American Society for Stereotactic and Functional Neurosurgery Annual Meeting, 2004.

59. Correia, S., Malloy, P.F., and Salloway, S. Diffusion tensor imaging and executive function in subcortical ischemic vascular disease and mild cognitive impairment. Paper presented at the annual meeting of the International Neuropsychological Society, St. Louis, MO, 2005.

p. 14 of 23

Revised 07/26/2019

60. Paul, R., Cohen, R., Malloy P., and Moser, D. Defining the natural history of Vascular Cognitive Impairment (VCI). Paper presented at the 2nd Congress of the International Society for Vascular Behavioral and Cognitive Disorders (VAS-COG), Florence, Italy, June, 2005.

61. Lee SY, Correia S, Tate DF, Paul RF, Zhang S, Salloway SP, Malloy PF, and Laidlaw DH. Quantitative Tract-of-Interest Metrics for White Matter Integrity Based on Diffusion Tensor MRI Data. Clinical Focus Presentation. 14th ISMRM Scientific Meeting & Exhibition, Seattle, Washington, May 2006.

62. Taub A; Lopes AC; D’Alcante CC; Mathis ME; Fuentes D; Hoexter MQ; Gouvea FS; Canteras M; Malloy P; Greenberg B; Noren G.; Rasmussen S; Busatto, G. Miguel, EC. Neuropsychological outcome following Gamma Knife Anterior Capsulotomy for obsessive-compulsive disorder: a pilot study. Brazilian Congress of Psychiatry, 2006.

63. Correia, S., Brennan-Krohn, T., Schlicting, E., Zhang, S., Laidlaw, D.H., Malloy, P.F. and Salloway, S. Diffusion-tensor imaging in vascular cognitive impairment and mild cognitive impairment: relationship with executive functioning. In Proceedings of the 2nd Congress of the International Society for Vascular, Cognitive and Behavioural Disorders, Florence, Italy, June 2005.

64. Malloy, P.F., Tremont, G., Grace, J., and Frakey, L. The Frontal Systems Behavior Scale (FrSBe) discriminates frontotemporal dementia from Alzheimer’s dementia. 5th International FTD Conference, San Francisco, CA, September, 2006.

65. Schlicting, E., Correia, S., Malloy, P., Salloway, S. N-back performance and standardized measures of processing speed, executive function, and working memory in mild cognitive impairment vs. normal controls. 35th Meeting of the International Neuropsychological Society, Portland WA, February, 2007.

66. Correia, S., Foley, J., Zhang, S., Laidlaw, D.H., Malloy, P.F. and Salloway, S. Processing speed in CADASIL: Relationship to cingulum vs. callosal fibers. 3rd Congress of the International Society for Vascular, Cognitive and Behavioural Disorders, San Antonia, TX, June 2005.

67. Schlicting E, Correia S, Malloy P, Salloway S. Classification of patients with amnestic mild cognitive impairment vs. normal controls based on N-back, Self-Ordered Pointing Task, and standardized cognitive measures. Poster presented at the 36th Meeting of the International Neuropsychological Society, Waikoloa, Hawaii, February, 2008

68. Patel K, Correia S, Epstein S, Schlicting S, Zhang S, Laidlaw D, Malloy P, Salloway S. Grey and white matter changes on MRI and diffusion-tensor imaging and cognitive function in mild cognitive impairment. Paper presented at the 36th Meeting of the International Neuropsychological Society, Waikoloa, Hawaii, February, 2008.

69. Song S, Correia S, Schlicting S, Malloy P, Salloway S. Executive impairment and MoCA performance in mild cognitive impairment and Alzheimer’s disease. Poster presented at the 36th Meeting of the International Neuropsychological Society, Waikoloa, Hawaii, February, 2008.

70. Deoni S., Correia S., Su T., Man J., Malloy P., & Salloway S. Investigating white matter myelin content across the spectrum of Alzheimer’s disease. Poster 17107. International Conference on Alzheimer’s Disease, July 2011, Paris.

71. Deoni S., Correia S., Su T., Man J., Malloy P., & Salloway S. Investigating limbic system myelin alteration in Alzheimer’s disease. Poster 17106. International Conference on Alzheimer’s Disease, July 2011, Paris.

72. Correia S., Rabinowitz A., Ahern D., D’Angelo C., Salloway S., Malloy P., Deoni S. White matter correlates of a new scoring metric for Trail Making Test part B. Alzheimer’s Association International Conference. July 14-19, 2012, Vancouver BC.

73. Piryatinksy, I., Baker, A., & Malloy, P. Performance characteristics on the TOMM and WMT in an aging population. Presented at the 40th Meeting of the International Neuropsychological Society, Montreal, Canada, February 15-18, 2012.

74. Mikos, A., Piryatinksy, I., Tremont, G., Fernandez, A., Hui, A., & Malloy, P. APOE4 is Associated with Increased Frontally Mediated Neurobehavioral Symptoms in Amnestic MCI and Alzheimer’s

p. 15 of 23

Revised 07/26/2019

Disease. Presented at the 40th Meeting of the International Neuropsychological Society, Montreal, Canada, February 15-18, 2012.

75. Smith Watts, AK, Farrer TJ, Walker L, Hartman ERT, Nelson Schmitt S, Lee A, Correia S, Salloway S, Malloy P, & Deoni S. Pilot Test of the Utility of a Visual Rating System for Identifying Artifacts in Diffusion-Tensor Imaging (DTI) Data. 43rd Annual Meeting of the International Neuropsychological Society, Feb 2015, Denver.

76. Farrer TJ, Smith Watts, AK, Hartman ERT, Correia S, van Huiden S, Salloway S, Malloy P, & Deoni S. Association between White Matter Hyperintensities and Alternate Scoring for Trail Making Test Part B. 43rd Annual Meeting of the International Neuropsychological Society, Feb 2015, Denver.

77. Kelly, P., Salloway, S., Gavett, R., Piryatinsky, I., Klinge, P., Malloy, P. Amyloid PET and shunt outcome in patients with idiopathic normal pressure hydrocephalus. Presented at the annual meeting of the American Geriatrics Society, Long Beach, CA, 2016.

78. Edwards, M., Hartman, E.R.T., Cabeen, R., Correia, S., Laidlaw, D. Malloy, P.F., Salloway, S.. Deoni, S. Association between network connectivity of select brain regions and cognitive abilities. Paper presented at the annual meeting of the International Neuropsychological Society, New Orleans, LA, 2016.

Invited addresses and workshops 1. Webster, J. S. & Malloy, P. F. Current issues in neuropsychological assessment and treatment.

Invited workshop presented at the annual meeting of the Mississippi Psychological Association, 1982. 2. Malloy, P. F. Frontal lobe dysfunction in psychiatric patients. Invited address presented at Concordia

University, 1985. 3. Malloy, P. F. Topographic mapping of evoked potentials: Frontal lobe activation in normals and

psychiatrics. Invited address presented at New York University Medical Center, 1985. 4. Malloy, P. F. Neuropsychological assessment and rehabilitation approaches in traumatic brain injury.

Invited address, Michael Webb Memorial Lecture Series, Butler Hospital, 1988. 5. Malloy, P. F. Computerized neuropsychological assessment. Invited workshop presented at the annual

meeting of the National Academy of Neuropsychology, Washington, 1989. 6. Malloy, P.F. (Organizer). Computers in neuropsychology. Conference held at Brown University,

Providence, 1989. 7. Malloy, P. F. Computerized neuropsychological assessment. Invited workshop presented at the annual

meeting of the National Academy of Neuropsychology, Reno, 1990. 8. Malloy, P.F. Computers in neuroimaging and neuropsychological assessment. Invited address at the

State University of New York, Binghamton, 1991. 9. Malloy, P.F. Neuropsychological assessment in the neuropsychiatric setting. Invited address

presented at Binghamton Psychiatric Center, Binghamton, NY, 1991. 10. Malloy, P.F. Clinical and research applications of neuroimaging. Invited workshop presented at the

annual meeting of the National Academy of Neuropsychology, Dallas, 1991. 11. Malloy, P.F. The neuropsychological basis of delusions. Invited address presented at West Virginia

School of Medicine, Morgantown, WV, 1992. 12. Malloy, P.F.. How to find quality training in neuropsychology. Invited address presented at the

annual meeting of the American Psychological Association, Washington, 1992. 13. Malloy, P.F. Clinical and research applications of neuroimaging for neuropsychologists. Invited

workshop presented at the Little Rock VA Medical Center, Little Rock, AR, 1992. 14. Malloy, P.F. The neuropsychology of delusions. Invited address presented at workshop entitled, “The

frontal lobes in neuropsychiatric disorders,” Brown University, 1992. 15. Malloy, P.F. The neuropsychology of delusions. Invited address presented at Taunton State Hospital,

Taunton, MA, January, 1993. 16. Malloy, P.F. & Duffy, J. Frontal lobe functions and neuropsychiatric disorders. Invited address

presented at Capitol District Psychiatric Center, Albany, NY, February, 1993

p. 16 of 23

Revised 07/26/2019

17. Malloy, P.F. The neuropsychology of delusions. Invited address presented at St. Joseph’s Hospital, Providence, RI, March, 1993.

18. Malloy, P.F. SPECT and neuropsychological assessment. Invited address presented at Providence VAMC, Providence, RI, March, 1993.

19. Duffy, J., Salloway, S., Malloy, P.F., Rogg, J. Neuroimaging: A primer for psychiatrists. Invited workshop presented at the annual meeting of the American Psychiatric Association, San Francisco, CA, May, 1993.

20. Duffy, J., Salloway, S., Malloy, P.F., Rogg, J. Neuroimaging: A primer for psychiatrists. Invited workshop presented at the annual meeting of the American Psychiatric Association, Philadelphia, PA, May, 1994.

21. Malloy, P.F. Understanding frontal lobe function and dysfunction. Invited workshop presented at the annual meeting of the National Academy of Neuropsychology, Orlando, FL, November, 1994.

22. Malloy, P.F. Orbital frontal lobe functions. Invited address presented at the National Institute of Mental Health, Brain Disorders Branch, Washington, DC, February, 1995.

23. Duffy, J., Salloway, S., Malloy, P.F., Rogg, J. Neuroimaging: A primer for psychiatrists. Invited workshop presented at the annual meeting of the American Psychiatric Association, Miami, FL, May, 1995.

24. Malloy, P.F. Understanding frontal lobe and memory dysfunction in traumatic brain injury. Invited workshop presented at the annual Traumatic Brain Injury workshop at Newport Hospital, Newport, RI, June, 1995.

25. Malloy, P.F. Frontal lobe syndromes: Clinical correlation of neuroimaging and behavioral data. Invited workshop at the annual meeting of the National Academy of Neuropsychology, San Francisco, 1995.

26. Rickler, K., Salloway, S., Malloy, P.F. Adult Attentiion Deficit Disorder: Diagnosis, course of illness, and treatment. Invited workshop presented at Butler Hospital, Providence, 1996.

27. Malloy, P.F. Frontal lobe syndromes: Neuroimaging and behavioral data. Invited workshop presented at the Philadelphia Neuropsychological Society, Philadelphia, 1996.

28. Malloy, P.F. Frontal lobe function and dysfunction. Invited workshop presented at Walter Reed Army Medical Center, Washington, DC, 1996.

29. Malloy, P.F. Frontal lobe syndromes and confabulation in traumatic brain injury. Invited address presented at JFK Medical Center, Edison, NJ, 1996.

30. Duffy, J., Salloway, S., Malloy, P.F., Rogg, J. Neuroimaging: A primer for psychiatrists. Invited workshop presented at the annual meeting of the American Psychiatric Association, New York, 1996.

31. Malloy, P.F. Determinants of neuropsychological impairment in substance abusers. Invited address at the symposium, "Alcohol, Development, Brain and Behavior," Binghamton University, Binghamton, NY, June, 1996.

32. Malloy, P.F. Secondary delusions. Invited address, Grand Rounds, University of Texas Health Sciences Center, San Antonio, 1999.

33. Malloy, P.F. Frontal lobe function and dysfunction. Invited workshop at the annual meeting of the National Academy of Neuropsychology, San Antonio, 1999.

34. Malloy, P.F. Introduction to neuroimaging for psychiatrists and psychologists. Invited workshop at the US Psychiatric and Mental Health Congress, Atlanta, 1999.

35. Malloy, P.F. Frontal lobe disorders in neuropsychiatry. Invited workshop at the US Psychiatric and Mental Health Congress, Atlanta, 1999.

36. Malloy, P.F. The neurologic basis of delusions. Invited workshop at the US Psychiatric and Mental Health Congress, Atlanta, 1999.

37. Malloy, P.F. Frontal systems impairment and “real world” functioning. Invited address at the West Coast Neuropsychology Conference, San Diego, 2000.

38. Malloy, P.F. and Aloia. M. Frontal dysfunction in neuropsychiatric disorders. Invited workshop at the Postdoctoral Institutes, American Psychological Association annual meeting, Washington, 2000.

p. 17 of 23

Revised 07/26/2019

39. Malloy, P.F. Frontal lobes and "real world" behaviors. Invited address at the 10th Anniversary Meeting of the Connecticut Neuropsychological Society, Hartford, 2000.

40. Malloy, P.F. Disorders of emotion in frontal systems lesions. Invited address at Tufts/New England Medical Center, Boston, October, 2000.

41. Malloy, P.F. Frontal dysfunction in neurologic and psychiatric disorders. Invited workshop at the Postdoctoral Institutes, American Psychological Association annual meeting, San Francisco, 2001.

42. Malloy, P.F. Introduction to neuroimaging for the practitioner. Invited workshop at the US Psychiatric and Mental Health Congress, Boston, November, 2001.

43. Malloy, P.F. Executive functioning and frontal lobe disorders. Invited workshop at the US Psychiatric and Mental Health Congress, Boston, 2001.

44. Malloy, P.F. Introduction to neuroimaging for neuropsychologists. Invited workshop at the Philadelphia Neuropsychology Society, Philadelphia, April, 2002.

45. Malloy, P.F. Executive functioning and frontal lobe disorders. Invited workshop at the Philadelphia Neuropsychology Society, Philadelphia, April, 2002.

46. Malloy, P.F. Neuroimaging for psychologists. Invited workshop at the Postdoctoral Institute of the American Psychological Association, Chicago, August, 2002.

47. Malloy, P.F. Executive functioning and frontal lobe disorders. Invited workshop at the Postdoctoral Institute of the American Psychological Association, Chicago, August, 2002.

48. Malloy, P.F. Frontal lobe disorders in head injury and stroke. Invited workshop presented at the HealthSouth 23rd Annual Neurorehabilitation Conference, Cambridge, MA, November, 2002.

49. Malloy, P.F. New methods for assessing frontal lobe functions. Invited address at the Behavioral Neuroscience Series, Brigham and Woman’s Hospital/Harvard University, Boston, MA, 2003

50. Malloy, P.F. Imaging in vascular dementia and vascular cognitive impairment. Invited discussant of symposium presented at the Annual Meeting of the International Neuropsychological Society, Honolulu, 2003.

51. Malloy, P.F. Combining behavioral and imaging measures of frontal dysfunction to predict functional decline in dementia. Invited address at the Alzheimer’s Disease Research Center, Boston University, Boston, MA, 2003.

52. Malloy, P.F. Frontal lobe function and dysfunction. Invited workshop at the Postdoctoral Institute, Annual Meeting of the American Psychological Association, Toronto, 2003.

53. Malloy, P.F. Neuroimaging for psychologists. Invited workshop at the Postdoctoral Institute, Annual Meeting of the American Psychological Association, Toronto, 2003.

54. Malloy, P.F. Functional neuroanatomy of the frontal lobes. Invited address at the 6th Annual Advances in Psychiatry Conference, University of Michigan Medical School Ann Arbor, 2004.

55. Malloy, P.F. Effective behavioral treatment of frontal systems disorders. Invited address at the 6th Annual Advances in Psychiatry Conference, University of Michigan Medical School Ann Arbor, 2004.

56. Malloy, P.F. Introduction to neuroimaging for the practitioner. Invited workshop at the US Psychiatric and Mental Health Congress, San Diego, 2004.

57. Malloy, P.F. Neuropsychiatric effects of cerebrovascular disease. Invited workshop at the US Psychiatric and Mental Health Congress, San Diego, 2004.

58. Malloy, P.F. The neuropsychiatric basis of delusions. Invited workshop at the US Psychiatric and Mental Health Congress, San Diego, 2004.

59. Malloy, P.F. Understanding frontal lobe function in neurological and psychiatric disorders. Invited workshop at the Postdoctoral Institute, Annual Meeting of the American Psychological Association, Washington, DC, 2005.

60. Malloy, P.F., Greenberg, B.D., Kubu, C.S. Deep brain stimulation and Gamma knife surgery for psychiatric disorder. Invited workshop at the Annual Meeting of the International Neuropsychological Society, Boston, 2006.

p. 18 of 23

Revised 07/26/2019

61. Malloy, P.F. Introduction to neuroimaging for the practitioner. Invited workshop at the US Psychiatric and Mental Health Congress, New Orleans, 2006.

62. Malloy, P.F. The neuropsychiatric basis of delusions. Invited workshop at the US Psychiatric and Mental Health Congress, New Orleans, 2006.

63. Malloy, P.F. and Correia, S. Neuroimaging of white matter. Invited workshop presented at the annual meeting of the National Academy of Neuropsychology, New York City, October, 2008.

64. Malloy, P.F. The Frontal Systems Behavior Scale (FrSBe): Development and use in neuropsychiatric populations. Psychiatry Grand Rounds at University of Mississippi Medical Center, February, 2009.

65. Malloy, P.F. Recent advances in frontal lobe research. Invited workshop at the Annual Meeting of the International Neuropsychological Society, Boston, 2011.

66. Malloy, P.F. and McLaughlin, N. Psychosurgery past, present and future. Invited workshop at the Annual Meeting of the International Neuropsychological Society, Boston, 2011.

67. Malloy, P.F The neuropsychiatric basis of content-specific delusions. Invited workshop at the Annual Meeting of the American Neuropsychiatric Association, New Orleans, 2012.

68. Salloway, S., Johnson, K., and Malloy, P.F. Diagnosing challenging cases using biomarkers and the new AD research criteria. Invited symposium at the Annual Meeting of the International Neuropsychological Society, Waikoloa, Hawaii, 2013.

69. Salloway, S. and Malloy, P.F. Use of amyloid imaging in clinical practice. Invited workshop at the Annual Meeting of the International Neuropsychological Society, Waikoloa, Hawaii, 2013.

70. Malloy, P.F. The neuropsychiatric basis of content-specific delusions. Invited address to the Department of Psychiatry, University of Connecticut Medical School, 2016.

71. Malloy, P.F. Frontotemporal dementia. Invited address to the Alzheimer’s New Jersey annual meeting, 2017.

72. Malloy, P.F. Frontal systems: Functions, syndromes and real-world correlates. Invited workshop for the New Jersey Neuropsychological Society, Union, NJ, 2018.

73. Malloy, P.F. Frontotemporal dementia. Invited address to the Massachusetts Neuropsychological Society, Boston MA 2018.

Grants: 1983-1988 Co-investigator, Environmental treatment of alcohol abusers. (NIAAA-AA05827-01A,). 1983-1988 Co-investigator, Prediction of treatment outcome in alcoholism using neuropsychological

tests. (NIAAA-AA06698-01). 1985 Co-investigator, Treatment of memory deficits in Korsakoff's patients with guanfacine. (A.

H. Robins Pharmaceuticals). 1988-1989 Co-investigator, Environmental treatment of alcohol abusers, competitive renewal.

(NIAAA-AA06698-04). 1989-1992 Co-investigator, Treatment of primary degenerative dementia with nimodopine. (Miles

Laboratories). 1993-1995 Principal Investigator. Multicenter comparison of placebo and Mentane in outpatients with

Alzheimer’s disease. (Hoechst Celenase Corp.) 1994-1995 Principal Investigator. Development of a computerized teaching program in neuroimaging.

(Wayland Collegium, Brown University). 1993-1995 Principal Investigator. Quantitative MRI analysis of subcortical white matter changes in

late-life onset depression. (Brown University Department of Psychiatry and Human Behavior).

1997-1998 Co-investigator. An eight-week, parallel group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression. (Pfizer Pharmaceuticals R-0552).

1997-2001 Principal Investigator. Relationship of MRI hyperintensities to treatment response in geriatric depression. (Pfizer Pharmaceuticals R-0552).

1997-2002 Co-investigator. Attentional and cognitive training in vital community elderly (ACTIVE). (NIA 5U101 NR4507-03).

p. 19 of 23

Revised 07/26/2019

1998-2001 Co-investigator. A multi-center evaluation of the efficacy and safety of donepezil hydrochloride in patients with dementia associated with cerebrovascular disease. (Eisai Inc. E2020-A0001-307).

1998-2000 Principal Investigator. A multicenter evaluation of the efficacy and safety of donepezil hydrochloride (E2020) in subjects with mild cognitive impairment. (Eisai/Pfizer E2020-A001-401).

1999-2004 Co- investigator. Heart disease, CNS dysfunction and outcome in the elderly. (PI: R. Cohen; NIH-NIA RO1 1999-PRG-1837)

2000-2001 Co-investigator. Combined Pharmacologic and Behavioral Intervention to Improve Memory in Alzheimer's Disease (PI: D. Cahn-Weiner; Alzheimer’s Association).

2000-2001 Co-investigator. Relationship of MRI hyperintensities to treatment response in geriatric depression. (PI: R. Krishnan; Pfizer Pharmaceuticals R-0552).

2000-2002 Co-investigator. Improving sleep and cognitive functioning in Alzheimer’s Disease. (M. Aloia, PI; Pfizer Pharmaceuticals, investigator-initiated).

2000-2001 Co-Investigator. A randomized double blind placebo-controlled trial to evaluate the efficacy and safety of galantamine in subjects with mild cognitive impairment (MCI) clinically at risk for development of clinically probable Alzheimer's Disease. (Jannsen Research Foundation GAL-INT-11).

2000-2004 Co-Principal Investigator, Butler site. Alzheimer’s disease prevention trial with estrogens. (PI: M. Sano; NIA)

2001-2003 Co-Principal Investigator. Pharmacologic vs. combined pharmacologic-behavioral treatment for apathy in Alzheimer’s disease. (Co-PI Patricia Boyle; Alzheimer’s Association, NIRG-01-2686).

2001-2002 Co-investigator. A double-blind, randomized pilot study to evaluate the effects of galantamine and donepezil on sleep and attention and GI tolerance in patients with mild to moderate Alzheimer’s disease. (Janssen Research Foundation, GAL-USA-24).

2002-2003 Co-Investigator. A 12-week, double-blind study in patients with mild to moderate Alzheimer’s disease who either continue ongoing Donepezil therapy or switch to Galantamine Hydrobromide. (Eisai Inc., E2020-A001-411).

2002-2003 Co-Investigator. Cognitive approach to maintaining self-care involvement. (PI-John Morris, NIA 3 U01 NR04507-0582).

2003 Co-Principal Investigator. A randomized, double-blind, placebo-controlled study of C105 (levo-amphetamine sulfate) to improve memory in patients suffering from anterior communicating aneurysm syndrome. (Sention, Inc. 22013, $22,552).

2003-2004 Co-Principal Investigator. A randomized, double-blind, placebo-controlled study of C105 to improve memory in patients suffering from mild cognitive impairment. (Sention, Inc. 22020, $157,400).

2003 Co-Investigator. A Phase II Double-Blind, Randomized, Dose-Ranging, Placebo-Controlled, Multicenter, Safety and Efficacy Evaluation of Three Doses of NS 2330 in Patients with Mild to Moderate Dementia of the Alzheimer’s Type. Boehringer Ingelheim Pharmaceuticals, Inc #1198.052, $51,020).

2003-2004 Co-Principal Investigator. A 24-week, multi-centered, randomized, double-blind, placebo-controlled evaluation of the efficacy, safety and tolerability of donepezil hydrochloride (E2020) in patients with dementia associated with cerebrovascular disease. (Eisai Medical Research, Inc. # E2020-A001-319, $132,820)

2003-2004 Co-Principal Investigator. An 80-week, randomized, multi-center, parallel-group, double-blind study of the efficacy and safety of atorvastatin 80 mg plus an acetylcholinesterase inhibitor versus an acetylcholinesterase inhibitor alone in the treatment of mild to moderate Alzheimer’s disease. (Pfizer, Inc #A2581078, $274,240).

2003-2005 Co-Investigator. Working memory and frontal white matter integrity in mild cognitive impairment. (Alzheimer’s Association. Stephen Correia, PI).

p. 20 of 23

Revised 07/26/2019

2003-2008 Principal Investigator. Brown Dementia Research Fellowship. (NIA #T32 AG0200498-01A1, $1,135,00).

2004-2005 Co-Investigator. A 1-year, multicenter, randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of Donepezil Hyudrochloride (E2020) in subjects with mild cognitive impairment. (Eisai # E2020-A001-412).

2004-2005 Co-investigator. Galantamine ER open label rapid dose escalation trial in Alzheimer’s disease. (Janssen Pharmaceutica #GAL-ALZ-303, $32,000)

2004-2005 Co-investigator. A double-blind, phase II, safety and efficacy evaluation of ONO-2506PO in patients with mild to moderate Alzheimer’s disease. (Ono Pharmaceutical Co. ONO-2506POU010, $214,890).

2004-2005 Co-Investigator. A phase III study of the efficacy and safety of Alzhemed™ in patients in mild to moderate Alzheimer’s disease (Neurochem #CL-758007, $231,000).

2004-2005 Co-Investigator. An open-label 8-week investigation of the safety and efficacy of escitalopram for the treatment of anxiety and depression in dementia caregivers. (Forest Laboratories).

2005-2006 Co-investigator. Metrics for qualifying white matter: Image analysis, testing and application. (Brown intramural Office of Research award, D. Laidlaw PI, $100,000).

2006-2008 Principal Investigator. Treatment of apathy in Alzheimer’s disease with Modafinil. Investigator initiated study. (Cephalon Pharmaceuticals. $80,000).

2006- 2011 Advisory Board, Development of a neuropsychological battery to measure executive dysfunction. (NINDS 05-02, Joel Kramer, PI).

2008- 2009 Co-investigator. A Phase 2 multicenter, randomized, double-blind, placebo-controlled study of the safety, tolerability, and pharmacokinetics of multiple intravenouse doses of PF-04360365 in patients with mild to moderate Alzheimer’s disease. (Pfizer A9951002).

2008- 2010 Co-investigator. A Phase III multicenter, randomized, double-blind, placebo-controlled parallel group, efficacy and safety trial of Bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer’s disease who are apolipoprotein E e4 carriers. (Elan 115727).

2008- 2010 Co-investigator. A Phase III multicenter, randomized, double-blind, placebo-controlled parallel group, efficacy and safety trial of Bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer’s disease who are apolipoprotein E e4 non-carriers. (Elan 115727).

2008- 2010 Co-investigator. A randomized, double-blind, placebo-controlled, dose-ranging, safety and efficacy study of oral ELND005 (AZD-103) in Alzheimer’s disease. (Elan D005-AD201).

2009- 2012 Principal investigator. CONCERT: A phase-3 multicenter, randomized, placebo-controlled double blind study of Dimebon in patients with mild-to-moderate Alzheimer’s disease on donepezil. (Medivation DIM18).

2007-2015 Co-investigator. Alzheimer Disease Neuroimaging Initiative (ADNI, ADNI-GO). (National Institute of Aging; Mark Weiner, PI).

2010- Co-investigator. Alzheimer's disease neuroimaging initiative-2 (ADNI-2) ADNI-039 2010-2014 Co-investigator. Imaging Myelin Loss Associated with Alzheimer's Disease. (Alzheimer's

Association; Sean Deoni, PI). 2012- Co-investigator. A randomized, double-blind, placebo-controlled multiple dose study to

assess the safety, tolerability, pharmacokinetics and pharmacodynamics of BIIB037 in subjects with prodromal or mild Alzheimer’s disease. (Biogen 221AD103).

2012-2015 Co-principal investigator. Amyloid imaging in normal pressure hydrocephalus. (A18). 2012- Co-investigator. A 12-month double blind, randomized, controlled feasibility study to

evaluate the safety, efficacy and tolerability of deep brain stimulation of the fornix (DBS-f) in patients with mild probable Alzheimer’s disease. (ADVANCE; Functional Neuromodulation DBS-FNMI-001)

2012- Co-investigator. Amyloid Pathology and shunt Outcome in Normal Pressure Hydrocephalus and 18F-AV-45-A14: Clinical Evaluation Using Florbetapir F-18 (18F-AV-45)

p. 21 of 23

Revised 07/26/2019

2013- Co-investigator. Effect of passive immunization on the progression of mild Alzheimer's disease: Solanezumab (LY2062430) versus placebo

2013- Co-investigator. DIAN-TU-001: A Phase II/III Randomized, Double-blind, Placebo-Controlled Multi-Center Study of 2 Potential Disease Modifying Therapies in Individuals at Risk for and with Dominantly Inherited Alzheimer’s Disease

2013- Co-investigator. A randomized, placebo controlled, parallel-group, double blind efficacy and safety trial of MK-8931 with a long term double-blind extension in subjects with mild to moderate Alzheimer's disease (Merck 017)

2014- Co-investigator. A Phase III, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 (SCH 900931) in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease (Prodromal AD).( Merck 019)2014- Co-investigator. Anti-amyloid treatment in asymptomatic Alzheimer's disease (A4 Study)

2014- Co-investigator. An open label, multicenter study, evaluating the safety and imaging characteristics of 18F-AV-1451 in cognitively healthy volunteers, subjects with Mild Cognitive Impairment, and subjects with Alzheimer’s disease

2015- Co-investigator. Longitudinal Evaluation of Amyloid Risk and Neurodegeneration: THE LEARN STUDY ADC-051

2015- Co-investigator. A Clinico-Pathological Study of the Correspondence Between F18-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology

2016- Co-investigator. CAPI015A2201J: A randomized, double-blind, placebo-controlled, two-cohort parallel group study to evaluate the efficacy of CAD106 and CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer's disease.

2016- Co-investigator. A Phase 2b/3 Randomized, Double-blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating the Efficacy and Safety of JNJ-54861911 in Subjects who are Asymptomatic At Risk for Developing Alzheimer’s Dementia.

2016- Co-investigator. Biogen 221AD301: A phase 3 multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of Aducanumab (BIIB037) in subjects with early Alzheimers disease

2016- Co-investigator. A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab versus Placebo in Prodromal Alzheimer’s Disease.

2016- Co-investigator. Longitudinal evaluation of [18F]GTP1 as a PET radioligand for imaging tau in the brain of patients with prodromal, mild and moderate Alzheimer’s disease compared to healthy volunteers. Molecular Neuroimaging (MNI)

2016- Co-investigator. An open label, multicenter study evaluating the imaging characteristics of a follow up 18F-AV-1451 scan in subjects that participated in the confirmatory cohort of 18F-AV-1451-A05

2016- Co-investigator. Imaging Dementia—Evidence for Amyloid Scanning (IDEAS) Study: A Coverage with Evidence Development Longitudinal Cohort Study

2017- Co-investigator. Alzheimer’s Disease Neuroimaging Initiative 3 (ADNI3) Teaching: 2003-2008 Director, Brown Dementia Research Fellowship. A NIA-supported T32 program designed

to train dementia researchers. The program involved faculty from four hospitals and six Brown departments.

2001- 2011 Associate Director, Brown University Psychology Training Consortium. Responsible for supervision of the postdoctoral research training portion of the Consortium, which involved over 30 trainees per year in T32 and F32 supported positions.

1984 - 2001 Neuropsychology Residency Track Coordinator. Coordinated and developed this track of the Brown University Psychology Consortium from its inception. Responsible for

p. 22 of 23

Revised 07/26/2019

administration of training of all neuropsychology students, organization of seminars for the track, and establishment of community/research placements.

1984- present Neuropsychology Residency Rotation Supervisor. Supervise Butler Hospital rotation for a full-time resident in the neuropsychology track of the Psychology Internship Consortium.

1987- present Neuropsychology Post-doctoral Fellowship Supervisor. Provide supervision for one to three full-time post-doctoral fellows in the neuropsychology track of the Psychology Training Consortium, conducting clinical and research activities at Butler.

1988- present Brown Alcohol & Addictions Center Post-Doctoral Supervisor. Provided mentorship for four full-time post-doctoral fellows, conducting clinical and research activities in neuropsychological aspects of alcohol abuse.

1984- present Neuropsychology Internship & Fellowship Seminar. Neuroimaging; Neuropsychiatric disorders; and Frontal lobe disorders

1990- present Psychiatry Resident PGY-3 Seminars. Frontal lobe syndromes; Sequelae of alcohol abuse; Detecting malingering and exaggeration

1990- present Psychiatry Resident PGY-4 Seminars Introduction to neuropsychological testing 1998- 2005 Geriatric Psychiatry Fellowship Seminar. Age-associated memory impairment;

Neuropsychological assessment in the elderly; Psychotic disorders in the elderly 1998-present Biomed 370-The Human Brain and Behavior. Frontal lobe function and dysfunction; The

neuropsychology of memory Editorial positions Editorial board Encyclopedia of Clinical Neuropsychology Editorial reviewer American Journal of Geriatric Psychiatry American Journal of Psychiatry Archives of Clinical Neuropsychology Assessment Biological Psychiatry Brain The Clinical Neuropsychologist European Neuropsychopharmacology Journal of Affective Disorders Journal of Clinical and Consulting Psychology Journal of Clinical and Experimental Neuropsychology Journal of the International Neuropsychological Society Journal of Nervous and Mental Disease Journal of Neuromuscular Disease Journal of Neuropsychiatry & Clinical Neuroscience Journal of Psychosomatic Research Neurobiology of Aging Neurology Neuropsychology Neuropsychology, Neuropsychiatry, and Behavioral Neurology Perceptual and Motor Skills Schizophrenia Research Research panels 2006 NIA Beeson Career Development Award (K12/23) review committee (ZAG1 ZIJ-9 M1)

p. 23 of 23

Revised 07/26/2019

2006-present Alzheimer’s Association Research Grant Program reviewer 2006-2012 NIH F31-F32 Fellowship Award review committee (ZRG1 F16 B 20) 2013 The Netherlands Organization of Health, Research and Development (ZonMw); Elderly

Medicine Research Grant reviewer 2015 NIH Health Disparities and Equity Promotion Study Section, Healthcare Delivery and

Methodologies IRG